Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphan.
The hypothermic effect of neurotensin (0.1 microgram) injected i.c.v. in mice is potentiated by the enkephalinase inhibitor thiorphan (10 micrograms, i.c.v.). This potentiation is not reversed by systemic naloxone. The hypothermic effect of neurotensin is not modified by the amino-peptidase inhibitor bestatin (50 micrograms, i.c.v.) nor by the angiotensin-converting enzyme inhibitor captopril (50 micrograms, i.c.v.). These data indicate the involvement of enkephalinase in the inactivation of neurotensin, at least when it is injected i.c.v.
D000603:Amino Acids, Sulfur / Q000008:administration & dosage*; D000818:Animals; D001831:Body Temperature / Q000187:drug effects*; D002216:Captopril / Q000008:administration & dosage; D004357:Drug Synergism; D010450:Endopeptidases / Q000378:metabolism*; D007276:Injections, Intraventricular; D007930:Leucine / Q000008:administration & dosage / Q000031:analogs & derivatives; D008297:Male; D051379:Mice; D009270:Naloxone / Q000008:administration & dosage*; D015260:Neprilysin; D009496:Neurotensin / Q000008:administration & dosage* / Q000378:metabolism; D015244:Thiorphan; D008625:Tiopronin / Q000008:administration & dosage* / Q000031:analogs & derivatives
D000603:Amino Acids, Sulfur; D009270:Naloxone; D009496:Neurotensin; D002216:Captopril; D015244:Thiorphan; D008625:Tiopronin; D010450:Endopeptidases; D015260:Neprilysin; D007930:Leucine; C012211:ubenimex